Want to see CANF full AI Analyst Report?
Compare Can-Fite BioPharma (CANF) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| CANFCan-Fite BioPharma | $1.63 | $5.09M | -0.25 | -80.71% | Moderate Buy | Unlock the CANF analyst price target with TipRanks Premium | CANF | Unlock the CANF top-analyst price target with TipRanks Premium | ||
| GNPXGenprex | $2.30 | $1.84M | -0.01 | -98.24% | ― | Unlock the GNPX analyst price target with TipRanks Premium | CANF vs GNPX | Unlock the GNPX top-analyst price target with TipRanks Premium | ||
| BCDABioCardia | $0.88 | $13.03M | -1.19 | -35.64% | Moderate Buy | Unlock the BCDA analyst price target with TipRanks Premium | CANF vs BCDA | Unlock the BCDA top-analyst price target with TipRanks Premium | ||
| PCSAProcessa Pharmaceuticals | $1.88 | $5.29M | -0.33 | -80.98% | ― | Unlock the PCSA analyst price target with TipRanks Premium | CANF vs PCSA | Unlock the PCSA top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CANF | Can-Fite BioPharma | 1.63 | -6.61 | -80.21% | |
| GNPX | Genprex | 2.23 | -114.37 | -98.09% | |
| BCDA | BioCardia | 0.90 | -0.49 | -35.18% | |
| PCSA | Processa Pharmaceuticals | 1.85 | -7.40 | -80.00% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
